This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Social Bookmarking   What's this?

The 21st Century

Scott M. Grundy, MD, PhD

Arch Intern Med. 1997;157(11):1177-1184.

Abstract
Recent clinical trials have demonstrated that reductions of serum low-density lipoprotein (LDL) levels substantially decrease the risk for coronary heart disease. These trials confirm other lines of evidence that high levels of LDL are a critical atherogenic factor. Aggressive lowering of LDL levels in high-risk patients promises to significantly reduce morbidity and mortality from coronary heart disease in the first third of the 21st century. However, several additional measures will be required to marginalize coronary heart disease in the 21st century. Other lipoprotein abnormalities and other risk factors, eg, cigarette smoking, hypertension, and diabetes mellitus, must be controlled to obtain the full benefit of LDL-lowering therapy. Moreover, the health care delivery system must be reorganized to put more emphasis on prevention. Although much can be achieved through application of current knowledge in prevention efforts, further advances through new research will be required to remove coronary heart disease as a major cause of death in the United States.

Arch Intern Med. 1997;157:1177-1184

Author Affiliations
From the Departments of Clinical Nutrition and Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

The Key to Atherogenicity
Michael E. Serjeant and Scott M. Grundy
Arch Intern Med. 1998;158(10):1156-1158.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent
Fouchier et al.
J. Med. Genet. 2005;42:e23-e23.
ABSTRACT | FULL TEXT  

Effects of resistance training and detraining on muscle strength and blood lipid profiles in postmenopausal women
Elliott et al.
Br. J. Sports. Med. 2002;36:340-344.
ABSTRACT | FULL TEXT  

Effect of Physician-Delivered Nutrition Counseling Training and an Office-Support Program on Saturated Fat Intake, Weight, and Serum Lipid Measurements in a Hyperlipidemic Population: Worcester Area Trial for Counseling in Hyperlipidemia (WATCH)
Ockene et al.
Arch Intern Med 1999;159:725-731.
ABSTRACT | FULL TEXT  

Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice
Lou et al.
Proc. Natl. Acad. Sci. USA 1998;95:12591-12595.
ABSTRACT | FULL TEXT  

The Key to Atherogenicity
Serjeant and Grundy
Arch Intern Med 1998;158:1156-1158.
FULL TEXT